Third Market Cleared
Amai Proteins has secured approval from the Israeli Ministry of Health for sweelin®, its precision-fermented sweet protein, marking the ingredient's third regulatory clearance in less than six months. The authorization covers commercialization across more than 25 food and beverage categories, giving manufacturers in Israel immediate access to a sweetening technology capable of replacing up to 70% of conventional sugar without reformulation penalties on taste or processing performance.
The Israel clearance follows FDA GRAS status in the United States and approval from Singapore's Food Agency earlier in 2026. That sequence — three distinct regulatory jurisdictions in under half a year — positions sweelin® among the faster-moving novel sweetener approvals in the precision-fermentation segment, a space that has drawn intensifying interest from ingredient buyers seeking alternatives to high-intensity synthetic sweeteners.
What the Ingredient Delivers
sweelin® is a monellin-based protein derived from the serendipity berry and produced via precision fermentation. At roughly 3,000 times the sweetness of sugar by weight, effective use levels are low enough to clear clean-label thresholds that matter to foodservice and retail brand teams. Published clinical data — cited by Amai as the first human study on a sweet protein — showed no effect on blood glucose, insulin, or GLP-1 levels, a finding that aligns with growing operator and manufacturer demand for ingredients compatible with GLP-1 medication users and metabolic-health positioning.
For foodservice suppliers and food manufacturers formulating for chain accounts, the GLP-1 compatibility claim adds a tangible merchandising hook at a moment when major QSR and fast-casual operators are actively auditing menus for reduced-sugar and lower-glycemic options. The ingredient is designed for compatibility with industrial food processing, which lowers the barrier for large-scale co-manufacturers supplying foodservice operators and chain-account customers.
Commercial Momentum
Dr. Amir Guttman, CEO of Amai Proteins, characterized the Israeli clearance as a particularly meaningful milestone, noting that sweelin® is the first sweet protein approved in Israel and that the company is headquartered in Rehovot. Amai is actively working with food and beverage manufacturers across its approved markets to move from regulatory status to commercial product launches.
For food and beverage processors supplying both retail and foodservice channels, the multi-market regulatory stack reduces the compliance burden of introducing sweelin®-sweetened SKUs in a sequential international rollout. The ingredient's authorization across the U.S., Singapore, and Israel also signals increasing regulator comfort with precision-fermented protein sweeteners as a category — a dynamic that could accelerate review timelines in additional markets where Amai may file next.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
